Immediately afterward, as downstream targets, PI3K/AKT/mTOR and MAPK/ERK pathway activity is weakened, resulting in a failure to promote the growth and metastasis of LC cells. The gene discussed is MTOR; the disease is laryngotracheoesophageal cleft.